EDC provides significant benefits over paper-based clinical trials such as improved data quality, faster data availability, and better safety monitoring. A major biotechnology company migrated two large, international pivotal trials from paper to EDC to accelerate timelines and cut costs. They saw immediate benefits including elimination of queries of omission and the ability to proactively handle safety events. The database lock time was also significantly reduced from 8 weeks to 4 weeks. Staff preferred EDC and found it saved time and allowed earlier decision making.